Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Meagan Effinger"'
Autor:
Eric D. Hsi, Robert M. Dean, Brian J. Bolwell, Meagan Effinger, Stephen D. Smith, Amanda L. Maggiotto, Brad Pohlman, John Sweetenham
Publikováno v:
American Journal of Hematology.
Mantle cell lymphoma (MCL) is a unique, recently recognized entity with a variable clinical course [1]. Its historical grouping as an indolent lymphoma belies its common behavior, which is generally aggressive and incurable, with a median survival of
Autor:
Anjali S. Advani, Yogen Saunthararajah, Mazyar Shadman, Mikkael A. Sekeres, Eric D. Hsi, Ronald Sobecks, Matt Kalaycio, Edward A. Copelan, Sarah Gibson, Meagan Effinger, Claudiu V. Cotta
Publikováno v:
Blood. 116:2736-2736
Abstract 2736 Background: Epigenetic instability and aberrant repression of tumor suppressor genes are fundamental aspects of acute myeloid leukemia (AML) biology. Current prognostic assays for AML focus on the genetic aspects of disease biology, for
Autor:
Stephen D. Smith, John Sweetenham, Meagan Effinger, Brian J. Bolwell, Eric D. Hsi, Amanda L. Maggiotto
Publikováno v:
Blood. 114:2703-2703
Abstract 2703 Poster Board II-679 Introduction: Mantle cell lymphoma (MCL) is an incurable disease with a highly variable course. Improvements in therapy have been impeded by the lack of a universal prognostic model, making risk stratification and co
Autor:
Matt Kalaycio, Ronald Sobecks, Meagan Effinger, Yogen Saunthararajah, Edward A. Copelan, Claudiu V. Cotta, Eric D. Hsi, Mikkael A. Sekeres, Mazyar Shadman, Sarah Gibson, Anjali S. Advani
Publikováno v:
Blood. 114:4681-4681
Abstract 4681 Background Histone acetylation is a post-translational modification used by proteins to regulate specific chromatin functions. Histone deacetylases (HDACs) play a pivotal role in the pathogenesis of a subset of acute myeloid leukemias (